Active
Company Information for REDX PHARMA LIMITED
BLOCK 33 MERESIDE, ALDERLEY PARK, MACCLESFIELD, SK10 4TG,
|
Company Registration Number
07368089
Private Limited Company
Active |
Company Name | |
---|---|
REDX PHARMA LIMITED | |
Legal Registered Office | |
BLOCK 33 MERESIDE ALDERLEY PARK MACCLESFIELD SK10 4TG Other companies in M2 | |
Company Number | 07368089 | |
---|---|---|
Company ID Number | 07368089 | |
Date formed | 2010-09-07 | |
Country | ENGLAND | |
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active | |
Lastest accounts | 30/09/2023 | |
Account next due | 30/06/2025 | |
Latest return | 07/09/2015 | |
Return next due | 05/10/2016 | |
Type of accounts | GROUP | |
VAT Number /Sales tax ID | GB172108923 |
Last Datalog update: | 2024-10-05 08:12:10 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Registered address | Last known status | Formation date | ||
---|---|---|---|---|
REDX PHARMA PLC | Unknown |
Officer | Role | Date Appointed |
---|---|---|
ANDREW WILLIAM BOOTH |
||
LISA MARY WHEWELL ANSON |
||
DOMINIC NICHOLAS JACKSON |
||
BERNHARD JURGEN KIRSCHBAUM |
||
PETER ERIC PRESLAND |
||
IAIN GLADSTONE ROSS |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
NORMAN MOLYNEUX |
Director | ||
NEIL DAVID MURRAY |
Director | ||
DAVID MUIR LAWRENCE |
Director | ||
SIMON WILLIAM THORN |
Company Secretary | ||
FRANK MURDOCH ARMSTRONG |
Director | ||
PETER MCPARTLAND |
Director | ||
PETER JACKSON |
Director | ||
PHILIP JOHN TOTTEY |
Director | ||
DEREK LINDSAY |
Director | ||
PHILIP LEON GOULD |
Director | ||
DENNIS WILLIAM PATRICK HALLAHANE |
Director | ||
DOUGLAS COLIN WALTER STELLMAN |
Director |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
REDX ONCOLOGY LTD | Director | 2018-02-07 | CURRENT | 2011-12-05 | Active | |
REDX ANTI-INFECTIVES LTD | Director | 2018-02-07 | CURRENT | 2012-07-09 | Liquidation | |
REDX IMMUNOLOGY LIMITED | Director | 2018-02-07 | CURRENT | 2014-04-16 | Active | |
GIELEN PARTNERS LIMITED | Director | 2013-10-24 | CURRENT | 2013-10-24 | Liquidation | |
ICONIC LABS PLC | Director | 2017-12-21 | CURRENT | 2016-05-24 | Active | |
BEAUTIFUL INFORMATION LIMITED | Director | 2015-10-01 | CURRENT | 2013-11-22 | Active | |
MAINVALLEY LIMITED | Director | 1994-09-27 | CURRENT | 1984-10-18 | Active | |
ROOKHILL LIMITED | Director | 1991-11-15 | CURRENT | 1979-09-28 | Active | |
CLAUSEGATE LIMITED | Director | 1991-11-15 | CURRENT | 1980-11-25 | Active | |
REDX ONCOLOGY LTD | Director | 2017-11-03 | CURRENT | 2011-12-05 | Active | |
REDX ANTI-INFECTIVES LTD | Director | 2017-11-03 | CURRENT | 2012-07-09 | Liquidation | |
REDX IMMUNOLOGY LIMITED | Director | 2017-11-03 | CURRENT | 2014-04-16 | Active | |
REDX MRSA LIMITED | Director | 2017-11-03 | CURRENT | 2014-09-04 | Liquidation |
Date | Document Type | Document Description |
---|---|---|
CONFIRMATION STATEMENT MADE ON 07/09/24, WITH UPDATES | ||
Resolutions passed:<ul><li>Resolution on securities</ul> | ||
Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed adopt articles</ul> | ||
Memorandum articles filed | ||
02/08/24 STATEMENT OF CAPITAL GBP 4212439.81 | ||
Resolutions passed:<ul><li>Resolution re-registration</ul> | ||
Re-registration of memorandum and articles of association | ||
Certificate of re-registration from Public Limited Company to Private | ||
Re-registration from a public company to a private limited company | ||
GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/23 | ||
Resolutions passed:<ul><li>Resolution passed removal of pre-emption</ul> | ||
Resolutions passed:<ul><li>Resolution passed removal of pre-emption<li>Resolution on securities</ul> | ||
APPOINTMENT TERMINATED, DIRECTOR SARAH LUCINDA GORDON WILD | ||
CONFIRMATION STATEMENT MADE ON 07/09/23, WITH NO UPDATES | ||
DIRECTOR APPOINTED DR JOSEPH ANDERSON | ||
APPOINTMENT TERMINATED, DIRECTOR THOMAS HENRY BURT | ||
GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/22 | ||
GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/22 | ||
Resolutions passed:<ul><li>Resolution on securities</ul> | ||
Resolutions passed:<ul><li>Resolution on securities</ul> | ||
Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed removal of pre-emption</ul> | ||
Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed removal of pre-emption</ul> | ||
Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed removal of pre-emption<li>Resolution Re-appointment of auditor, re-election of director 14/03/2023</ul> | ||
Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed removal of pre-emption<li>Resolution Re-appointment of auditor, re-election of director 14/03/2023</ul> | ||
CS01 | CONFIRMATION STATEMENT MADE ON 07/09/22, WITH NO UPDATES | |
Appointment of Claire Penelope Solk as company secretary on 2022-09-01 | ||
Termination of appointment of Andrew William Booth on 2022-09-01 | ||
TM02 | Termination of appointment of Andrew William Booth on 2022-09-01 | |
AP03 | Appointment of Claire Penelope Solk as company secretary on 2022-09-01 | |
SH01 | 27/07/22 STATEMENT OF CAPITAL GBP 3349114.58 | |
RES11 | Resolutions passed:
| |
SH01 | 07/06/22 STATEMENT OF CAPITAL GBP 3333531.61 | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/21 | |
RES10 | Resolutions passed:
| |
DIRECTOR APPOINTED DR ROBERT ANDREW DONALD SCOTT | ||
AP01 | DIRECTOR APPOINTED DR ROBERT ANDREW DONALD SCOTT | |
AP01 | DIRECTOR APPOINTED DR JANE VERONICA GRIFFITHS | |
SH01 | 27/09/21 STATEMENT OF CAPITAL GBP 2752822.05 | |
CS01 | CONFIRMATION STATEMENT MADE ON 07/09/21, WITH UPDATES | |
AUD | AUDITOR'S RESIGNATION | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR IAIN GLADSTONE ROSS | |
AP01 | DIRECTOR APPOINTED MS NATALIE BERNER | |
RES10 | Resolutions passed:
| |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/20 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR JAMES ROBERT MEAD | |
SH01 | 22/12/20 STATEMENT OF CAPITAL GBP 2738872.13 | |
RES11 | Resolutions passed:
| |
CS01 | CONFIRMATION STATEMENT MADE ON 07/09/20, WITH NO UPDATES | |
AP01 | DIRECTOR APPOINTED MR THOMAS HENRY BURT | |
MR04 | STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 073680890003 | |
MR01 | REGISTRATION OF A CHARGE / CHARGE CODE 073680890004 | |
RES11 | Resolutions passed:
| |
SH01 | 21/07/20 STATEMENT OF CAPITAL GBP 1952474.13 | |
AP01 | DIRECTOR APPOINTED MRS SARAH LUCINDA GORDON WILD | |
TEND | London Stock Exchange corporate action. Tender/Acquisition/Takeover/Purchase Offer of ORD GBP0.01 for COAF: UK600129763Y2020 ASIN: GB00BSNB6S51 | |
RES11 | Resolutions passed:
| |
PSC01 | NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL JEREMY CHARLES GREEN | |
PSC07 | CESSATION OF MOULTON GOODIES LTD AS A PERSON OF SIGNIFICANT CONTROL | |
TEND | London Stock Exchange corporate action. Tender/Acquisition/Takeover/Purchase Offer of ORD GBP0.01 for COAF: UK600129763Y2020 ASIN: GB00BSNB6S51 | |
MR01 | REGISTRATION OF A CHARGE / CHARGE CODE 073680890003 | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/19 | |
SH01 | 28/02/20 STATEMENT OF CAPITAL GBP 1900087.03 | |
PSC02 | Notification of Moulton Goodies Ltd as a person with significant control on 2020-01-21 | |
PSC09 | Withdrawal of a person with significant control statement on 2020-03-05 | |
SH01 | 22/01/20 STATEMENT OF CAPITAL GBP 1785087.03 | |
RES11 | Resolutions passed:
| |
MR04 | STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 073680890002 | |
CS01 | CONFIRMATION STATEMENT MADE ON 07/09/19, WITH NO UPDATES | |
MR01 | REGISTRATION OF A CHARGE / CHARGE CODE 073680890002 | |
MR04 | STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 073680890001 | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/18 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR DOMINIC NICHOLAS JACKSON | |
AP01 | DIRECTOR APPOINTED JAMES ROBERT MEAD | |
CS01 | CONFIRMATION STATEMENT MADE ON 07/09/18, WITH UPDATES | |
AP01 | DIRECTOR APPOINTED LISA MARY WHEWELL ANSON | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/17 | |
PSC08 | Notification of a person with significant control statement | |
PSC09 | Withdrawal of a person with significant control statement on 2018-03-12 | |
CS01 | CONFIRMATION STATEMENT MADE ON 07/09/17, WITH UPDATES | |
AM10 | NOTICE OF ADMINISTRATOR'S PROGRESS REPORT:LIQ. CASE NO.1 | |
AM21 | NOTICE OF END OF ADMINISTRATION:LIQ. CASE NO.1 | |
AM10 | NOTICE OF ADMINISTRATOR'S PROGRESS REPORT:LIQ. CASE NO.1 | |
AM21 | NOTICE OF END OF ADMINISTRATION:LIQ. CASE NO.1 | |
AP03 | SECRETARY APPOINTED MR ANDREW WILLIAM BOOTH | |
AP03 | SECRETARY APPOINTED MR ANDREW WILLIAM BOOTH | |
AP01 | DIRECTOR APPOINTED MR IAIN GLADSTONE ROSS | |
AP01 | DIRECTOR APPOINTED MR DOMINIC NICHOLAS JACKSON | |
AP01 | DIRECTOR APPOINTED MR PETER ERIC PRESLAND | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR NORMAN MOLYNEUX | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR NEIL MURRAY | |
TM02 | Termination of appointment of Simon William Thorn on 2017-05-16 | |
AD01 | REGISTERED OFFICE CHANGED ON 06/11/17 FROM 2nd Floor 110 Cannon Street London EC4N 6EU | |
AM06 | Notice of deemed approval of proposals | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR DAVID MUIR LAWRENCE | |
AM03 | Statement of administrator's proposal | |
AM12 | NOTICE OF ORDER LIMITING DISCLOSURE OF STATEMENT OF AFFAIRS OR PROPOSALS IN ADMINISTRATION/O/C DISCLOSE:LIQ. CASE NO.1 | |
AM04 | NOTICE OF EXTENSION OF TIME TO DELIVER ADMINISTRATOR'S PROPOSALS:LIQ. CASE NO.1 | |
AM05 | NOTICE OF EXTENSION OF TIME TO SEEK APPROVAL OF ADMINISTRATOR'S PROPOSALS:LIQ. CASE NO.1 | |
AD01 | REGISTERED OFFICE CHANGED ON 13/06/2017 FROM FLOOR 9, LOWRY HOUSE 17 MARBLE STREET MANCHESTER GREATER MANCHESTER M2 3AW | |
AM01 | NOTICE OF ADMINISTRATOR'S APPOINTMENT:LIQ. CASE NO.1:IP NO.00014372,00009644 | |
RES12 | VARYING SHARE RIGHTS AND NAMES | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR PETER MCPARTLAND | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR FRANK ARMSTRONG | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR PETER JACKSON | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/16 | |
LATEST SOC | 08/03/17 STATEMENT OF CAPITAL;GBP 1264779.14 | |
SH01 | 01/03/17 STATEMENT OF CAPITAL GBP 1264779.14 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
SH01 | 15/02/17 STATEMENT OF CAPITAL GBP 996979.56 | |
LATEST SOC | 05/10/16 STATEMENT OF CAPITAL;GBP 935526.38 | |
CS01 | CONFIRMATION STATEMENT MADE ON 07/09/16, WITH UPDATES | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR PHILIP TOTTEY | |
SH01 | 15/04/16 STATEMENT OF CAPITAL GBP 935526.38 | |
RES11 | DISAPPLICATION OF PRE-EMPTION RIGHTS | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
AP01 | DIRECTOR APPOINTED MR DAVID MUIR LAWRENCE | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR DEREK LINDSAY | |
AP01 | DIRECTOR APPOINTED DR BERNHARD JURGEN KIRSCHBAUM | |
RES11 | DISAPPLICATION OF PRE-EMPTION RIGHTS | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/15 | |
LATEST SOC | 24/09/15 STATEMENT OF CAPITAL;GBP 649812.09 | |
AR01 | 07/09/15 FULL LIST | |
RES13 | CHANGE OF NAME AND THE RE-REGISTRATION AS A PUBLIC COMPANY 18/03/2015 | |
RES01 | ADOPT ARTICLES 18/03/2015 | |
LATEST SOC | 22/06/15 STATEMENT OF CAPITAL;GBP 649812.09 | |
SH01 | 27/03/15 STATEMENT OF CAPITAL GBP 649812.09 | |
AUD | AUDITOR'S RESIGNATION | |
AD03 | REGISTER(S) MOVED TO SAIL ADDRESS 114-REG MEM | |
AD02 | SAIL ADDRESS CREATED | |
SH01 | 17/03/15 STATEMENT OF CAPITAL GBP 473341.50 | |
SH01 | 13/03/15 STATEMENT OF CAPITAL GBP 6981.27 | |
RES13 | COMPANY BUSINESS 16/03/2015 | |
RES01 | ALTER ARTICLES 16/03/2015 | |
AP01 | DIRECTOR APPOINTED MR PHILIP JOHN TOTTEY | |
MAR | REREGISTRATION MEMORANDUM AND ARTICLES | |
RES02 | REREG PRI TO PLC; RES02 PASS DATE:18/03/2015 | |
AUDS | AUDITORS' STATEMENT | |
AUDR | AUDITORS' REPORT | |
RR01 | APPLICATION BY A PRIVATE COMPANY FOR RE-REGISTRATION AS A PUBLIC COMPANY | |
BS | BALANCE SHEET | |
CERT5 | CERTIFICATE OF REREGISTRATION FROM PRIVATE TO PLC | |
SH20 | STATEMENT BY DIRECTORS | |
CAP-SS | SOLVENCY STATEMENT DATED 13/03/15 | |
SH19 | 17/03/15 STATEMENT OF CAPITAL GBP 6311.22 | |
RES06 | REDUCE ISSUED CAPITAL 16/03/2015 | |
RP04 | SECOND FILING WITH MUD 07/09/14 FOR FORM AR01 | |
RP04 | SECOND FILING WITH MUD 07/09/13 FOR FORM AR01 | |
RP04 | SECOND FILING WITH MUD 07/09/12 FOR FORM AR01 | |
RP04 | SECOND FILING WITH MUD 07/09/11 FOR FORM AR01 | |
ANNOTATION | Clarification | |
SH20 | STATEMENT BY DIRECTORS | |
SH19 | 03/02/15 STATEMENT OF CAPITAL GBP 6776.11 | |
CAP-SS | SOLVENCY STATEMENT DATED 02/02/15 | |
RES13 | REDUCTION OF SHARE PREMIUM ACCOUNT 30/01/2015 | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/14 | |
ANNOTATION | Clarification | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
ANNOTATION | Clarification | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
SH01 | 30/09/14 STATEMENT OF CAPITAL GBP 6776.11 | |
RES13 | COMPANY BUSINESS 15/09/2014 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
AR01 | 07/09/14 FULL LIST | |
AR01 | 07/09/14 FULL LIST | |
RP04 | SECOND FILING WITH MUD 07/09/13 FOR FORM AR01 | |
ANNOTATION | Clarification | |
AP01 | DIRECTOR APPOINTED MR FRANK MURDOCH ARMSTRONG | |
ANNOTATION | Clarification | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
RP04 | SECOND FILING FOR FORM SH01 | |
MR01 | REGISTRATION OF A CHARGE / CHARGE CODE 073680890001 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR PHILIP GOULD | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR DENNIS HALLAHANE | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/09/13 | |
AR01 | 07/09/13 FULL LIST | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/09/12 | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
AR01 | 07/09/12 FULL LIST | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/09/11 | |
AP01 | DIRECTOR APPOINTED MR DENNIS WILLIAM PATRICK HALLAHANE | |
AR01 | 07/09/11 FULL LIST | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR DOUGLAS STELLMAN | |
AP01 | DIRECTOR APPOINTED PETER MCPARTLAND | |
SH02 | SUB-DIVISION 20/09/10 | |
RES12 | VARYING SHARE RIGHTS AND NAMES | |
RES01 | ADOPT ARTICLES 20/09/2010 | |
AP03 | SECRETARY APPOINTED SIMON WILLIAM THORN | |
AP01 | DIRECTOR APPOINTED DR NEIL DAVID MURRAY | |
AP01 | DIRECTOR APPOINTED DEREK LINDSAY | |
AP01 | DIRECTOR APPOINTED PETER JACKSON | |
AP01 | DIRECTOR APPOINTED DR PHILIP LEON GOULD | |
AP01 | DIRECTOR APPOINTED DOUGLAS COLIN WALTER STELLMAN | |
MODEL ARTICLES | MODEL ARTICLES ADOPTED: PRIVATE LIMITED BY SHARES (AMENDED PROVISIONS) | |
NEWINC | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
Other Corp | 2017-11-08 |
Notice of | 2017-08-25 |
Appointmen | 2017-05-31 |
Total # Mortgages/Charges | 4 |
---|---|
Mortgages/Charges outstanding | 1 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 3 |
Charge Type | Date of Charge | Charge Status | Mortgagee |
---|---|---|---|
Outstanding | LIVERPOOL CITY COUNCIL |
The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as REDX PHARMA LIMITED are:
Origin | Destination | Date | Import Code | Imported Goods classification description |
---|---|---|---|---|
29339980 | Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl | |||
29339980 | Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
29189990 | Carboxylic acids with additional oxygen function, their anhydrides, halides, peroxides and peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. only with alcohol, phenol, aldehyde or ketone function, and 2,6-dimethoxybenzoic acid, dicamba [ISO], sodium phenoxyacetate, and 2,4,5-T [ISO] [2,4,5-trichlorophenoxyacetic acid] and its salts and esters) | |||
29339980 | Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl | |||
38210000 | Prepared culture media for the development or maintenance of micro-organisms "incl. viruses and the like" or of plant, human or animal cells | |||
35079090 | Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease) | |||
29341000 | Heterocyclic compounds containing an unfused thiazole ring, whether or not hydrogenated, in the structure | |||
35079090 | Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease) | |||
30012010 | Extracts of glands or other organs or of their secretions, of human origin, for organo-therapeutic uses | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
29350090 | Sulphonamides (excl. 3-{1-[7-"hexadecylsulphonylamino"-1H-indole-3-yl]-3-oxo-1H, 3H-naphtho[1,8-cd]pyran-1-yl}-N,N-dimethyl-1H-indole-7-sulphonamide and metosulam "ISO") | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
35079090 | Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease) | |||
29420000 | Separate chemically defined organic compounds, n.e.s. | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
29420000 | Separate chemically defined organic compounds, n.e.s. | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
35079090 | Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease) | |||
27122090 | Paraffin wax containing < 0,75% by weight of oil (excl. synthetic paraffin wax of a molecular weight of >= 460 but <= 1.560) | |||
30029030 | Animal blood prepared for therapeutic, prophylactic or diagnostic uses | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
90189084 | Instruments and appliances used in medical, surgical or veterinary sciences, n.e.s. | |||
30021098 | Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
30021098 | Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
30012090 | Extracts of glands or other organs or of their secretions, of animals, for organo-therapeutic uses | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
30012090 | Extracts of glands or other organs or of their secretions, of animals, for organo-therapeutic uses | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
29420000 | Separate chemically defined organic compounds, n.e.s. | |||
90189084 | Instruments and appliances used in medical, surgical or veterinary sciences, n.e.s. | |||
90189084 | Instruments and appliances used in medical, surgical or veterinary sciences, n.e.s. | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
30012010 | Extracts of glands or other organs or of their secretions, of human origin, for organo-therapeutic uses | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
29339980 | Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl | |||
29339980 | Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl | |||
29173995 | Aromatic polycarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. esters of orthophthalic acid, phthalic anhydride, terephthalic acid and its salts, dimethyl terephthalate, ester or anhydride of tetrabromophthalic acid, benzene-1,2,4-tricarboxylic acid, isophthaloyl dichloride containing by weight <= 0,8% of terephthaloyl dichloride, naphthalene-1,4,5,8-tetracarboxylic acid, tetrachlorophthalic anhydride | |||
29319090 | Separate chemically defined organo-inorganic compounds (excl. organo-sulphur compounds, tributyltin compounds, tetramethyl lead, tetraethyl lead, dimethyl methylphosphonate, methylphosphonoyl difluoride "methylphosphonic difluoride", methylphosphonoyl dichloride "methylphosphonic dichloride" and those of mercury and (5-Ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl methyl methylphosphonate; bis[(5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl] methylphosphonate; 2,4,6-tripro | |||
29189990 | Carboxylic acids with additional oxygen function, their anhydrides, halides, peroxides and peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. only with alcohol, phenol, aldehyde or ketone function, and 2,6-dimethoxybenzoic acid, dicamba [ISO], sodium phenoxyacetate, and 2,4,5-T [ISO] [2,4,5-trichlorophenoxyacetic acid] and its salts and esters) | |||
29173920 | Ester or anhydride of tetrabromophthalic acid; benzene-1,2,4-tricarboxylic acid; isophthaloyl dichloride, containing by weight 0,8 % or less of terephthaloyl dichloride; naphthalene-1,4,5,8-tetracarboxylic acid; tetrachlorophthalic anhydride; sodium 3,5-bis(methoxycarbonyl)benzenesulphonate | |||
29420000 | Separate chemically defined organic compounds, n.e.s. | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) |
For goods imported into the United Kingdom, only imports originating from outside the EU are shown
Initiating party | Event Type | Other Corp | |
---|---|---|---|
Defending party | REDX PHARMA PLC | Event Date | 2017-11-08 |
Initiating party | Event Type | Appointment of Administrators | |
Defending party | REDX PHARMA PLC | Event Date | 2017-05-24 |
In the High Court of Justice Liverpool District Registry Names and Address of Administrators: Jason Daniel Baker (IP No. 9644 ) and Miles Needham (IP No. 14372 ) both of FRP Advisory LLP , 2nd Floor, 110 Cannon Street, London, EC4N 6EU : Further details contact: The Joint Administrators, Email: cp.london@frpadvisory.com or Tel: 020 3005 4000 . Alternative contact: Email: Michael.Quinn@frpadvisory.com Ag IF21595 | |||
Initiating party | Event Type | Notice of Intended Dividends | |
Defending party | REDX PHARMA PLC | Event Date | 2017-05-24 |
In the High Court of Justice Liverpool District Registry Notice is hereby given that I Miles Needham, the Joint Administrator of the above named Company, appointed on 24 May 2017, intend to declare and distribute a first and final dividend within the period of two months from the last date of proving mentioned below. All creditors of the Company are required, on or before 19 September 2017, which is the last date for proving, to prove their debt by sending to me a written statement of the amount they claim to be due from the Company and, if so requested, to provide such further details or produce such documentary or other evidence as may appear to the Joint Administrator to be necessary. A distribution may be made without regard to the claim of any person in respect of a debt not proved. A creditor who has not proved his debt before the last date for proving mentioned above is not entitled to disturb, by reason that he has not participated in the dividend, the distribution of that dividend or any other dividend declared before his debt is proved. Date of Appointment: 24 May 2017 Office Holder Details: Jason Daniel Baker (IP No. 9644 ) of FRP Advisory LLP , 2nd Floor, 110 Cannon Street, London, EC4N 6EU and Miles Needham (IP No. 14372 ) of FRP Advisory LLP , 4 Beaconsfield Road, St Albans, Hertfordshire, AL1 3RD Further details contact: The Joint Administrators, E-mail: cp.london@frpadvisory.com . Alternative contact: Matthew Kesek. Ag LF51573 | |||
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |